Article | July 20, 2026

Clinical Trial Recruitment Strategies For Rare Disease Studies

Source: 20/20 Onsite
Rare diseases, medical-GettyImages-2199746424

Rare disease clinical trials face an uphill battle from day one, largely because geographic scarcity forces a small pool of vulnerable patients to travel long distances for specialized care. When the logistical burden becomes too high, standard trials suffer from missed enrollment timelines, inflated budgets, and compromised data integrity. To protect complex clinical endpoints, clinical operations teams must shift their focus from expecting patients to travel to bringing the trial directly to the patient.

Embracing a point-of-need delivery model completely reshapes this dynamic, reducing patient travel burdens by over 80%. By deploying mobile clinics equipped with specialized diagnostic tools and trained technicians, sponsors can execute protocol-adherent assessments right in the participant's community. Reviewing geographic barriers during early protocol design ensures a seamless, patient-centric strategy that secures data quality and keeps timelines on track.

Discover how decentralized execution can rescue your recruitment strategy and safeguard your study's endpoints.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader